Novel vaccines protecting against the development of allergic disorders: a double-edged sword?

被引：18

作者：

Erb, KJ ^{[1
]}

Wohlleben, G ^{[1
]}

机构：

[1] Univ Wurzburg, Ctr Infect Dis, D-97070 Wurzburg, Germany

来源：

CURRENT OPINION IN IMMUNOLOGY | 2002年 / 14卷 / 05期

关键词：

D O I：

10.1016/S0952-7915(02)00385-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The severity and incidence of allergic disorders is steadily increasing despite the widespread use of steroids and other drugs. Recent results obtained in animals suggest that it may be possible to develop novel anti-allergy vaccines for human use, thereby stopping this alarming worldwide increase in allergic diseases. The most promising approaches are the induction of allergen-specific T helper 1 or allergen-specific T regulatory responses. However, both approaches potentially harbour negative side effects that need to be ruled out before vaccinating young children - the best candidates for the primary prevention of allergic disorders.

引用

页码：633 / 643

页数：11

共 98 条

[1] HELMINTH INFECTION RESULTS IN DECREASED VIRUS-SPECIFIC CD8+ CYTOTOXIC T-CELL AND TH1-CYTOKINE RESPONSES AS WELL AS DELAYED VIRUS CLEARANCE [J].

ACTOR, JK ;

SHIRAI, M ;

KULLBERG, MC ;

BULLER, RML ;

SHER, A ;

BERZOFSKY, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :948-952

[2] Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen [J].

Akbari, O ;

DeKruyff, RH ;

Umetsu, DT .

NATURE IMMUNOLOGY, 2001, 2 (08) :725-731

[3] Role of interleukin 10 in specific immunotherapy [J].

Akdis, CA ;

Blesken, T ;

Akdis, M ;

Wüthrich, B ;

Blaser, K .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106

[4] The potential of peptide immunotherapy in allergy and asthma. [J].

Ali F.R. ;

Kay A.B. ;

Larché M. .

Current Allergy and Asthma Reports, 2002, 2 (2) :151-158

[5] Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease [J].

Arkwright, PD ;

David, TJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (03) :531-534

[6] Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL®) adjuvant:: a new allergy vaccine for dust mite allergy [J].

Baldrick, P ;

Richardson, D ;

Wheeler, AW .

VACCINE, 2001, 20 (5-6) :737-743

[7] Dendritic cells as vectors for therapy [J].

Banchereau, J ;

Schuler-Thurner, B ;

Palucka, AK ;

Schuler, G .

CELL, 2001, 106 (03) :271-274

[8] Immunobiology of dendritic cells [J].

Banchereau, J ;

Briere, F ;

Caux, C ;

Davoust, J ;

Lebecque, S ;

Liu, YT ;

Pulendran, B ;

Palucka, K .

ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+

[9] In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].

Barrat, FJ ;

Cua, DJ ;

Boonstra, A ;

Richards, DF ;

Crain, C ;

Savelkoul, HF ;

de Waal-Malefyt, R ;

Coffman, RL ;

Hawrylowicz, CM ;

O'Garra, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616

[10] Interleukin-10 regulation in normal subjects and patients with asthma [J].

Borish, L ;

Aarons, A ;

Rumbyrt, J ;

Cvietusa, P ;

Negri, J ;

Wenzel, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (06) :1288-1296

← 1 2 3 4 5 6 7 8 9 10 →